Bixiye
QP94-24 MHCP Pharmacy Benefit Exclusion for Darzalex Faspro®, Supprelin® LA and Visudyne®
Taariikhda uu dhaqangalayo Barnaamijka: Des 23, 2024
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 791 - 800 ee natiijooyinka 3167
Bixiye
QP96-24 Prescription Drug Electronic Prior Authorization (ePA) Submission Process Update
Taariikhda uu dhaqangalayo Barnaamijka: Des 23, 2024
Bixiye
QP97-24 Commercial Pharmacy Benefit Exclusion for oxytocin, Pitocin® and Prepidil® Gel
Taariikhda uu dhaqangalayo Barnaamijka: Des 23, 2024
Bixiye
QP95-24 Commercial Pharmacy Benefit Exclusion for lanreotide, Ultomiris® and Visudyne®
Taariikhda uu dhaqangalayo Barnaamijka: Des 23, 2024
Sharciga & Xeerar
Notice-of-Privacy-Practices-F7676R15.pdf
Sharciga & Xeerar
Notice-of-Privacy-Practices-F7676R15.pdf
Sharciga & Xeerar
HIPAA Notice of Privacy Practices
Caafimaad iyo Ladnaan
2025 Preventive Prenatal Benefits
Caafimaad iyo Ladnaan
2025 Detailed Description of Preventive Services